NICE guidance on olaparib for maintenance treatment of patients with relapsed, platinum-sensitive, BRCA mutation-positive ovarian cancer.

Sorry, there's nothing here.

Cite this paper

@article{Tucker2016NICEGO, title={NICE guidance on olaparib for maintenance treatment of patients with relapsed, platinum-sensitive, BRCA mutation-positive ovarian cancer.}, author={Helen Tucker and Zoe Charles and J. Kirk Robertson and Jane E. Adam}, journal={The Lancet. Oncology}, year={2016}, volume={17 3}, pages={277-8} }